CanSino Biologics Inc (CJH) — Cash Flow Reinvestment Rate

Latest as of December 2021: 0.43x

CanSino Biologics Inc (CJH) has a Cash Flow Reinvestment Rate of 0.43x as of December 2021, reinvesting €344.15 Million (capex €284.07 Million plus investments €-60.09 Million) from operating cash flow of €806.73 Million. See CJH free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.43x

(Capex + Investments) / Operating CF

Total Reinvested

€344.15 Million

Capex + Investments

Operating Cash Flow

€806.73 Million

EUR

Capital Expenditures

€284.07 Million

EUR

CanSino Biologics Inc Cash Flow Reinvestment Rate (2021–2025)

Historical reinvestment intensity for CanSino Biologics Inc across 2 annual periods. For the full cash flow conversion analysis, see CanSino Biologics Inc (CJH) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for CanSino Biologics Inc (2021–2025)

Year-by-year capital reinvestment analysis for CanSino Biologics Inc. See CanSino Biologics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2025	10.78x	€839.60 Million	€77.86 Million	€243.90 Million	▲ +748.3%
2021	1.27x	€2.61 Billion	€2.05 Billion	€1.20 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow